Please wait

Exhibit 107

Calculation of Filing Fee Tables

Schedule 13E-3

(Form Type)

Pardes Biosciences, Inc.

(Exact Name of Registrant and Name of Person Filing Statement)

Table 1 - Transaction Value

 

       

    Transaction    

valuation

       Fee Rate                

    Amount of    

Fee Filing

    
                     

Fees to Be Paid

       $     136,088,312.78(1)              0.0001102         $     14,996.93(2)    
                     

Fees Previously Paid

       $     —                    $     —    
                     

Total Transaction Valuation

       $     136,088,312.78                              
                     

Total Fees Due for Filing

                                 $     14,996.93    
                     

Total Fees Previously Paid

                                 $     —    
                     

Total Fee Offsets

                                 $     14,996.93(3)    
                     

Net Fee Due

                                 $     0.00    

Table 2 - Fee Offset Claims and Sources

 

                             
           Registrant  
or Filer  
Name  		       

Form or  
Filing  

Type  

         File Number          

Initial Filing  

Date  

         Filing Date          

Fee Offset  

Claimed  

       

Fee Paid with  

Fee Offset  

Source  

                                           
Fee Offset Claims                          SC TO-T               005-93142             July 28, 2023                       $     14,996.93(3)              
                                           
Fee Offset Sources             (3)            SC TO-T               005-93142                           July 28, 2023                      $     14,996.93(3) 

 

(1)

Estimated solely for the purpose of calculating the filing fee. The transaction value was calculated by adding (i) the product of (a) $2.19, which is the sum of (1) $2.02, the base price per share of common stock of Pardes Biosciences, Inc. (each, a “Share”), and (2) $0.17, the maximum additional amount of cash price per Share, and (b) the sum of 62,008,506 Shares issued and outstanding (including restricted Shares) and (ii) the product of (a) the difference between (1) $2.19 and (2) an exercise price of $2.05 (the weighted-average exercise price of the outstanding options) and (b) stock options representing the right to purchase an aggregate of 2,069,176 Shares. The calculation of the transaction value is based on information as of July 24, 2023.

(2)

The amount of the filing fee was calculated by multiplying the transaction valuation by 0.0001102.

(3)

FS Development Holdings II, LLC previously paid $14,996.93 upon the filing of its Schedule TO-T on July 28, 2023 in connection with the transaction reported hereby.